Dyadic International Inc (DYAI)

Currency in USD
0.3270
-0.0231(-6.60%)
Closed·
0.32700.0000(0.00%)
·
Trading near 52-week Low
DYAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.31500.3500
52 wk Range
0.31501.6000
Key Statistics
Prev. Close
0.3501
Open
0.35
Day's Range
0.315-0.35
52 wk Range
0.315-1.6
Volume
188.37K
Average Volume (3m)
145.95K
1-Year Change
-63.8674%
Book Value / Share
-0.066
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DYAI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.5000
Upside
+1,581.96%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Dyadic International Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.5000
(+1,581.96% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy4.00+1,123.24%5.00MaintainAug 13, 2026

Dyadic International Inc Earnings Call Summary for Q3/2026

  • Dyadic reported Q3 2026 revenue of $449K, missing estimates by 70.2% and down 61% YoY; posted $0.04 loss per share vs. $0.03 forecast.
  • Company achieved first direct protein sales but acknowledged slower-than-expected customer adoption, particularly in regulated therapeutic applications.
  • Cash position declined to $6.0M from $8.6M at year-end 2025, with monthly burn rate of approximately $590K continuing into Q4 2026.
  • Management expects $225K Q4 payment from Inzymes; Strive Nutrition supply deal targets 10 tons initially, potentially scaling to 200 tons in 2027.
  • Strategic shift toward partnerships announced to leverage external capital and infrastructure rather than independently funding commercialization efforts.
Last Updated: 13/11/2026, 00:22
Read Full Transcript

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-0.04 / -0.03
Revenue / Forecast
450K / 1.51M
EPS Revisions
Last 90 days

DYAI Income Statement

Compare DYAI to Peers and Sector

Metrics to compare
DYAI
Peers
Sector
Relationship
P/E Ratio
−1.6x−1.5x−0.2x
PEG Ratio
0.11−0.530.00
Price/Book
−5.0x2.4x2.6x
Price / LTM Sales
3.1x61.2x2.8x
Upside (Analyst Target)
-112.3%63.4%
Fair Value Upside
Unlock1.3%9.5%Unlock

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.29M3.54%499.92K
Other Institutional Investors
8.13M22.32%3.16M
Public Companies & Retail Investors
27.02M74.14%10.48M
Total
36.44M100.00%14.14M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Empery Asset Management, LP9.18%3,346,2751,298
Bandera Master Fund L.P3.80%1,383,308537

People Also Watch

57.410
LQDA
-1.22%
148.88
ANF
-1.07%
0.2853
ACTU
-3.61%
80.25
AAON
+1.84%

FAQ

What Is the Dyadic (DYAI) Stock Price Today?

The Dyadic stock price today is 0.3270 USD.

What Stock Exchange Does Dyadic Trade On?

Dyadic is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Dyadic?

The stock symbol for Dyadic is "DYAI."

What Is the Dyadic Market Cap?

As of today, Dyadic market cap is 11.7900M USD.

What Is Dyadic's Earnings Per Share (TTM)?

The Dyadic EPS (TTM) is -0.21.

When Is the Next Dyadic Earnings Date?

Dyadic will release its next earnings report on Mar 31, 2027.

From a Technical Analysis Perspective, Is DYAI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Dyadic Stock Split?

Dyadic has split 0 times.

How Many Employees Does Dyadic Have?

Dyadic has 5 employees.

What is the current trading status of Dyadic (DYAI)?

As of Nov 13, 2026, Dyadic (DYAI) is trading at a price of 0.3270 USD, with a previous close of 0.3501 USD. The stock has fluctuated within a day range of 0.3150 USD to 0.3500 USD, while its 52-week range spans from 0.3150 USD to 1.6000 USD.

What Is Dyadic (DYAI) Price Target According to Analysts?

The average 12-month price target for Dyadic is 5.5000 USD, with a high estimate of 7 USD and a low estimate of 4 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,581.96% Upside potential.

What Is the DYAI Premarket Price?

DYAI's last pre-market stock price is 0.3500 USD. The pre-market share volume is 18,530.0000, and the stock has decreased by -0.0001, or -0.0300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.